Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-10-23
2007-10-23
Chan, Christina (Department: 1644)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C424S184100, C424S185100, C424S810000, C514S014800
Reexamination Certificate
active
09857097
ABSTRACT:
The present invention relates to a pharmaceutical composition for the prevention of alloimmunization of a subject or the immunosuppression of a response elicited by alloimmunization of a subject or an autoimmune haemolytic disease for said composition comprising an immunologically effective epitope of a rhesus protein or an immunologically active analogue or derivative thereof.
REFERENCES:
Barker et al. Blood [1997] 90(7):2701-2715.
Stott et al. Blood [1998] 92(10), part 1, supplement 1, p. 25A.
VanderVegt, FP et al [1993] J. Exp. Med. 177:1587-1592.
Barker Robert Norman
Urbaniak Stanislaw Joseph
Aberdeen University
Chan Christina
Commom Services Agency for the Scottish Health Service
Licata & Tyrrell P.C.
VanderVegt F. Pierre
LandOfFree
Allo and auto-reactive T-cell epitopes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Allo and auto-reactive T-cell epitopes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Allo and auto-reactive T-cell epitopes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3867445